Anhui Anke Biotechnology (Group) Co., Ltd. 300009.SZ Stock
Anhui Anke Biotechnology (Group) Co., Ltd. Price Chart
Anhui Anke Biotechnology (Group) Co., Ltd. 300009.SZ Financial and Trading Overview
Contents
- Anhui Anke Biotechnology (Group) Co., Ltd. Price Chart
- Anhui Anke Biotechnology (Group) Co., Ltd. 300009.SZ Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Anhui Anke Biotechnology (Group) Co., Ltd.
- Q&A For Anhui Anke Biotechnology (Group) Co., Ltd. Stock
| Anhui Anke Biotechnology (Group) Co., Ltd. stock price | 9.8 CNY |
| Previous Close | 9.93 CNY |
| Open | 9.95 CNY |
| Bid | 10 CNY x 0 |
| Ask | 10.01 CNY x 0 |
| Day's Range | 9.92 - 10.07 CNY |
| 52 Week Range | 8.34 - 12.29 CNY |
| Volume | 7.42M CNY |
| Avg. Volume | 13.08M CNY |
| Market Cap | 16.75B CNY |
| Beta (5Y Monthly) | 0.408219 |
| PE Ratio (TTM) | 23.27907 |
| EPS (TTM) | 0.51 CNY |
| Forward Dividend & Yield | 0.25 (2.52%) |
| Ex-Dividend Date | May 19, 2023 |
| 1y Target Est | N/A |
300009.SZ Valuation Measures
| Enterprise Value | 15.51B CNY |
| Trailing P/E | 23.27907 |
| Forward P/E | 15.166666 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.002576 |
| Price/Book (mrq) | 4.8948655 |
| Enterprise Value/Revenue | 6.485 |
| Enterprise Value/EBITDA | 18.228 |
Trading Information
Anhui Anke Biotechnology (Group) Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.408219 |
| 52-Week Change | 2.16% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 12.29 CNY |
| 52 Week Low | 8.34 CNY |
| 50-Day Moving Average | 10.67 CNY |
| 200-Day Moving Average | 10.4 CNY |
300009.SZ Share Statistics
| Avg. Volume (3 month) | 13.08M CNY |
| Avg. Daily Volume (10-Days) | 10.57M CNY |
| Shares Outstanding | 1.67B |
| Float | 990.64M |
| Short Ratio | N/A |
| % Held by Insiders | 42.09% |
| % Held by Institutions | 5.48% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.25 |
| Trailing Annual Dividend Yield | 2.51% |
| 5 Year Average Dividend Yield | 119.00% |
| Payout Ratio | 0.4653 |
| Last Split Factor | 1.2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 29.93% |
| Operating Margin (ttm) | 32.19% |
| Gross Margin | 76.75% |
| EBITDA Margin | 35.57% |
Management Effectiveness
| Return on Assets (ttm) | 11.46% |
| Return on Equity (ttm) | 22.15% |
Income Statement
| Revenue (ttm) | 2.39B CNY |
| Revenue Per Share (ttm) | 1.46 CNY |
| Quarterly Revenue Growth (yoy) | 11.40% |
| Gross Profit (ttm) | 1.83B CNY |
| EBITDA | 851.02M CNY |
| Net Income Avi to Common (ttm) | 716.04M CNY |
| Diluted EPS (ttm) | 0.43 |
| Quarterly Earnings Growth (yoy) | 7.39% |
Balance Sheet
| Total Cash (mrq) | 1.33B CNY |
| Total Cash Per Share (mrq) | 0.79 CNY |
| Total Debt (mrq) | 28.02M CNY |
| Total Debt/Equity (mrq) | 0.77 CNY |
| Current Ratio (mrq) | 3.089 |
| Book Value Per Share (mrq) | 2.045 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 750.53M CNY |
| Levered Free Cash Flow (ttm) | 226.46M CNY |
Profile of Anhui Anke Biotechnology (Group) Co., Ltd.
| Country | China |
| State | N/A |
| City | Hefei |
| Address | AnkeBio Building |
| ZIP | 230088 |
| Phone | 86 551 6531 9890 |
| Website | https://www.ankebio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Anhui Anke Biotechnology (Group) Co., Ltd. develops, produces, and markets pharmaceutical products in China and internationally. The company offers recombinant human growth hormone for injection under the Ansomone name; and recombinant human interferon alpha 2b lyophilized powder, liquid, and prefilled syringe for injection, as well as recombinant human interferon alpha 2b cream, eye drop, and suppository under the Anterferon name. It also provides anti-sperm antibody, semen leukocyte peroxidase staining, one-time semen processing, sperm hypo-osmotic staining, sperm life detection, sperm staining detection, sperm acrosin detection, sperm DNA fragmentation staining, and leptin and immunohistochemical diagnostic kits. In addition, the company offers adhesive plasters, oral solutions, topical preparations, and ointments; peptide APIs; beauty care and anti-aging products; and synthetic drugs in the form of oral powders, dripping pills, and tablets and capsules. Further, it provides autosomal, sex chromosome, autosomal and sex chromosome combination, and other kits, as well as paternity testing set packages; tumor biological immunotherapy products; and DNA testing professional services. The company was founded in 2000 and is based in Hefei, China.
Q&A For Anhui Anke Biotechnology (Group) Co., Ltd. Stock
What is a current 300009.SZ stock price?
Anhui Anke Biotechnology (Group) Co., Ltd. 300009.SZ stock price today per share is 9.8 CNY.
How to purchase Anhui Anke Biotechnology (Group) Co., Ltd. stock?
You can buy 300009.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Anhui Anke Biotechnology (Group) Co., Ltd.?
The stock symbol or ticker of Anhui Anke Biotechnology (Group) Co., Ltd. is 300009.SZ.
Which industry does the Anhui Anke Biotechnology (Group) Co., Ltd. company belong to?
The Anhui Anke Biotechnology (Group) Co., Ltd. industry is Biotechnology.
How many shares does Anhui Anke Biotechnology (Group) Co., Ltd. have in circulation?
The max supply of Anhui Anke Biotechnology (Group) Co., Ltd. shares is 1.68B.
What is Anhui Anke Biotechnology (Group) Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Anhui Anke Biotechnology (Group) Co., Ltd. PE Ratio is 19.21568700 now.
What was Anhui Anke Biotechnology (Group) Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Anhui Anke Biotechnology (Group) Co., Ltd. EPS is 0.51 CNY over the trailing 12 months.
Which sector does the Anhui Anke Biotechnology (Group) Co., Ltd. company belong to?
The Anhui Anke Biotechnology (Group) Co., Ltd. sector is Healthcare.